Guobang Pharma Ltd. (605507.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 9.82B |
| Enterprise Value | 10.02B |
| P/E Ratio | 13.46 |
| PEG Ratio | -0.65 |
| Price/Sales Ratio | 2.05 |
| Price/Book Ratio | 1.46 |
| Enterprise/Revenue | 2.17 |
| Enterprise/EBITDA | 10.93 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.12 |
| Operating Margin | 0.13 |
AD
Management Effectiveness
| Return On Assets | 0.06 |
| Return On Equity | 0.08 |
Income Statement
| Revenue | 5.99B |
| Revenue/Share | 8.03 |
| Gross Profit | 1.46B |
| EBITDA | 1.45B |
| Net Income | 820.82M |
| Diluted EPS | 1.48 |
Balance Sheet
| Total Cash | 2.51B |
| Total Cash/Share | 3.3 |
| Total Debt | 2.2B |
| Total Debt/Equity | 0.26 |
| Current Ratio | 2.33 |
| Book Value Per Share | 11.05 |
Price History
| 52-Week Change | -7.67 |
| 52-Week High | 21.41 |
| 52-Week Low | 14.34 |
| Moving Average 50 Days | 15.66 |
| Moving Average 200 Days | 17.33 |
Statistics
| Average Volume | 5.53M |
| Shares Outstanding | 782.35M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.6 |
| Trailing Annual Dividend Yield | 3.75 |
| Payout Ratio | 0.01 |
| Last Split Factor | 7:5 |
| Last Split Date | May 29, 2026 |
AD
